A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Clinical trial NCT07260877 · RECRUITING

Trial details

NCT number: NCT07260877
Sponsor: Ventus Therapeutics U.S., Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Lupus Erythematosus (CLE)Systemic Lupus Erythematosus SLE SLE (Systemic Lupus)CLE

Start date: 2025-12-03
Primary completion: 2026-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.